Vilon Bioregulator Research

Vilon peptide represents one of the shortest bioactive compounds studied in laboratory research, consisting of just two amino acids (Lys-Glu). Scientific investigations reveal this dipeptide demonstrates measurable effects across multiple cellular pathways in controlled research environments.

Gene Expression Regulation

Laboratory studies show KE peptide binds directly to double-stranded DNA in cell nuclei, specifically targeting GCGC sequences found in 642 gene promoters[1]. This binding mechanism allows the peptide to regulate multiple genes simultaneously in research cell cultures[2].

Research demonstrates the peptide interacts with histone proteins, potentially altering chromatin structure in laboratory conditions. These modifications may influence gene accessibility and transcription factor binding in controlled studies[1].

Immune System Modulation

In vitro experiments reveal Vilon modulates cytokine production in cultured immune cells. The peptide specifically targets the CHUK gene, which encodes components for NF-κB signaling pathway regulation[1].

Laboratory research shows the compound stimulates T-cell differentiation and promotes CD4 and CD5 molecule expression in thymic cell cultures. Studies demonstrate up to 6-fold reduction in inflammatory cytokine synthesis in stimulated cell preparations[2].

Cellular Aging Research

Research indicates Vilon normalizes telomere length in stimulated lymphocyte cultures across different age groups in laboratory conditions. The peptide increases euchromatin proportion while decreasing heterochromatin in aging cell models[2].

Gene expression analysis reveals the compound regulates aging-related genes including IGF1, FOXO1, TERT, and NFκB in mesenchymal stem cell cultures. Laboratory studies show reduced apoptosis markers in aging cell preparations treated with the peptide[2].

Cardiovascular Research Applications

Studies demonstrate Vilon influences ACE2 gene expression, which encodes angiotensin-converting enzyme 2 in cardiovascular research models. The peptide also regulates AKT1 and AKT2 genes linked to cellular survival and angiogenesis pathways[1].

Metabolic and Stress Response Studies

Research shows the peptide affects heat shock protein synthesis and cellular stress response mechanisms in laboratory conditions. The compound influences genes encoding proteins involved in energy production and oxidative stress tolerance[2].

Laboratory investigations reveal Vilon regulates matrix metalloproteinase-9 expression and increases Ki-67 synthesis in cultured fibroblast preparations. These findings suggest potential applications in tissue repair research models[2].

Certificate of Analysis (COA) for Every Batch

A Certificate of Analysis (COA) is a document that verifies a compound’s identity, purity, and batch quality through independent laboratory testing. Every compound from BioLongevity Labs ships with a COA tied to its specific batch, so researchers can confirm exactly what they received before it enters a protocol.

Each COA reports results from third-party laboratory analysis, including:

• High-performance liquid chromatography (HPLC) for purity, typically confirmed at 99% or higher
• Liquid chromatography mass spectrometry (LC-MS) for molecular identity and mass confirmation
• Sterility and endotoxin screening where applicable
• Chemical contaminant and residual solvent checks

COAs are sourced from independent certified labs rather than in-house testing alone, giving researchers a verifiable record of molecular integrity for each batch. All compounds are supplied for research use only.